Richard Dale Childress, MS, MD, FACE

Dr. Childress received his Master’s Degree in Cellular Biology and his medical degree from LSU-HSC in Shreveport, LA before moving to Memphis where he completed his Internal Medicine residency and Endocrinology fellowship training at UTHSC-Memphis. Dr. Childress joined The Endocrine Clinic in late 2004 and divides his clinical time between TEC and the Memphis VA Medical Center. He is a clinical assistant professor of medicine at the University of Tennessee, staff endocrinologist at the VA and serves on the Human Research Institutional Review Board at the VA. He also serves as the Chief Medical Officer for the molecular genetics research company, Genome Explorations, Inc. He has served on the Board of Directors for the Southern States chapter of the American Association of Clinical Endocrinologists and served as the president of the chapter in 2010-2011.

Dr. Childress is a member of, and fellow of, the American Association of Clinical Endocrinologists, and is a member of The Endocrine Society and the American Thyroid Association. He has served as regional faculty and consultant for Pfizer, Glaxo-Smith Kline, Merck, Sanofi-aventis, and Novo-Nordisk.

He has served as a peer reviewer for the Archives of Internal Medicine, and the Annals of Internal Medicine.

Dr. Childress is actively involved in clinical and pharmaceutical research at both TEC and at the VA, and has served as an investigator for the several NIH-sponsored trials. His primary research interest is in the use of molecular genetics in diagnosing disease, and TEC served as a research site in the development of a molecular test for thyroid cancer which is now commercially available through Veracyte, Inc.

Dr. Childress' clinical interests are focused in two areas: metabolic syndrome (insulin resistance, diabetes, polycystic ovarian syndrome, high cholesterol), and thyroid disease especially thyroid cancer.

Richard Childress, MD